This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Scoula Internazionale Superiore Di Studi Avanzati—Sissa, University of California, University of Southern California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Evgeniy I Kreydin: Innovator in Neuromodulation Technology
Introduction
Evgeniy I Kreydin is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of neuromodulation, particularly through his innovative patent related to spinal cord stimulation. His work has the potential to impact various medical applications and improve patient outcomes.
Latest Patents
Kreydin holds a patent for a "Transcutaneous electrical spinal cord neuromodulator and uses thereof." This invention encompasses various embodiments of electrical stimulators designed for transcutaneous and/or epidural stimulation. The stimulator is configured to provide multiple stimulation patterns, including monophasic electrical stimulation with a DC offset, delayed biphasic electrical stimulation with charge balance, and amplitude modulated dynamic stimulation, among others.
Career Highlights
Throughout his career, Kreydin has been associated with prestigious institutions such as the University of California and Scuola Internazionale Superiore Di Studi Avanzati—Sissa. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kreydin has collaborated with notable individuals in his field, including Parag Gad and Victor Reggie Edgerton. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Evgeniy I Kreydin is a prominent figure in the realm of neuromodulation, with a patent that showcases his innovative approach to spinal cord stimulation. His contributions to the field are significant and hold promise for future advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile